Literature DB >> 21938487

Death receptor 5 and neuroproliferation.

Yanli Niu1, Yongqiang Li, Jianfeng Zang, Hongen Huang, Jiexin Deng, Zhanjun Cui, Dongming Yu, Jinbo Deng.   

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand or Apo2 ligand is a member of the tumor necrosis factor superfamily of cytokines that induces apoptosis upon binding to its death domain-containing transmembrane receptors, death receptors 4 and 5 (DR4, DR5). However, DR5 is also expressed in the developing CNS where it appears to play a role unrelated to apoptosis, and instead may be involved in the regulation of neurogenesis. We report on the distribution of DR5 expression in mouse hippocampus, cerebellum, and rostral migratory stream (RMS) of olfactory bulb from embryonic (E) day 16 (E16) to postnatal (P) day (P180). At E16, DR5-positive cells were distributed widely in embryonic hippocampus with strong immunostaining in the developing dentate gyrus. In newborn hippocampus, DR5-positive cells were predominantly located in proliferative zones, such as dentate gyrus, subventricular zone, and RMS. After postnatal day 7 (P7), the number of DR5-positive cells decreased, and cells with intense fluorescence were primarily restricted to the subgranular layer (SGL), although the granular cell layer showed weak fluorescence. After P30, only few DR5-positive cells were found in SGL, and mature granule cells were negative for DR5 expression. To address whether DR5 expression is a restricted to progenitor cells and newborn neurons, we performed 5-bromo-deoxyuridine labeling. We report that proliferative cells in the SGL selectively express DR5, with lower levels of expression in cells positive for doublecortin, a marker of newborn neurons. In addition, the stem cells in intestine, cerebellum, and RMS were also demonstrated to be DR5-positive. In the meantime, in cerebellum, DR5-positive cells were also positive for glial fibrillary acidic protein, a marker of proliferative Bergmann cells. We conclude that DR5 is selectively expressed by neuroprogenitor cells and newborn neurons, suggesting that the DR5 death receptor is likely to play a key role in neuroproliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21938487     DOI: 10.1007/s10571-011-9757-3

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  50 in total

1.  TR3 death receptor expression in the normal and ischaemic brain.

Authors:  D C Harrison; J Roberts; C A Campbell; B Crook; R Davis; K Deen; J Meakin; D Michalovich; J Price; M Stammers; P R Maycox
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Selective TRAIL-triggered apoptosis due to overexpression of TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug resistant CEM/VBL1000 human leukemia cells.

Authors:  Soo-Jung Park; Khadijeh Bijangi-Vishehsaraei; Ahmad R Safa
Journal:  Int J Biochem Mol Biol       Date:  2010-07-18

Review 3.  TRAIL and other TRAIL receptor agonists as novel cancer therapeutics.

Authors:  Christina Falschlehner; Tom M Ganten; Ronald Koschny; Uta Schaefer; Henning Walczak
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

4.  The prognostic value of TRAIL and its death receptors in cervical cancer.

Authors:  John H Maduro; Maartje G Noordhuis; Klaske A ten Hoor; Elisabeth Pras; Henriette J G Arts; Jasper J H Eijsink; Harry Hollema; Constantijne H Mom; Steven de Jong; Elisabeth G E de Vries; Geertruida H de Bock; Ate G J van der Zee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-01       Impact factor: 7.038

5.  TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.

Authors:  Larisa L Belyanskaya; Algirdas Ziogas; Sally Hopkins-Donaldson; Stefanie Kurtz; Hans-Uwe Simon; Rolf Stahel; Uwe Zangemeister-Wittke
Journal:  Lung Cancer       Date:  2008-02-21       Impact factor: 5.705

Review 6.  TRAIL-receptor antibodies as a potential cancer treatment.

Authors:  Donald J Buchsbaum; Andres Forero-Torres; Albert F LoBuglio
Journal:  Future Oncol       Date:  2007-08       Impact factor: 3.404

7.  A placental protective role for trophoblast-derived TNF-related apoptosis-inducing ligand (TRAIL).

Authors:  X Bai; J L R Williams; S L Greenwood; P N Baker; J D Aplin; I P Crocker
Journal:  Placenta       Date:  2009-08-11       Impact factor: 3.481

8.  WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.

Authors:  Isabelle Bisson; David M Prowse
Journal:  Cell Res       Date:  2009-06       Impact factor: 25.617

9.  DR5 activation of caspase-8 induces DC maturation and immune enhancement in vivo.

Authors:  Michael A Chattergoon; Karuppiah Muthumani; Yutaka Tamura; Mathura Ramanathan; Jason P Shames; Vera Saulino; Tara M Robinson; Luis J Montaner; David B Weiner
Journal:  Mol Ther       Date:  2007-12-18       Impact factor: 11.454

10.  TRAIL, DR5 and caspase 3-dependent apoptosis in vessels of diseased human temporomandibular joint disc. An immunohistochemical study.

Authors:  C Loreto; L E Almeida; M R Migliore; M Caltabiano; R Leonardi
Journal:  Eur J Histochem       Date:  2010       Impact factor: 3.188

View more
  3 in total

Review 1.  Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2.

Authors:  U Bertsch; C Röder; H Kalthoff; A Trauzold
Journal:  Cell Death Dis       Date:  2014-08-28       Impact factor: 8.469

2.  Vanillin and 4-hydroxybenzyl alcohol promotes cell proliferation and neuroblast differentiation in the dentate gyrus of mice via the increase of brain-derived neurotrophic factor and tropomyosin-related kinase B.

Authors:  Jeong-Hwi Cho; Joon Ha Park; Ji Hyeon Ahn; Jae-Chul Lee; In Koo Hwang; Seung Min Park; Ji Yun Ahn; Dong Won Kim; Jun Hwi Cho; Jong-Dai Kim; Young-Myeong Kim; Moo-Ho Won; Il-Jun Kang
Journal:  Mol Med Rep       Date:  2016-02-19       Impact factor: 2.952

3.  Activation of TRAIL-DR5 pathway promotes sensorineural degeneration in the inner ear.

Authors:  Shyan-Yuan Kao; Vitor Y R Soares; Arthur G Kristiansen; Konstantina M Stankovic
Journal:  Aging Cell       Date:  2016-01-21       Impact factor: 9.304

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.